Defibrillator/Related Articles: Difference between revisions
Jump to navigation
Jump to search
imported>Daniel Mietchen m (Robot: encapsulating subpages template in noinclude tag) |
imported>Housekeeping Bot m (Automated edit: Adding CZ:Workgroups to Category:Bot-created Related Articles subpages) |
||
Line 23: | Line 23: | ||
{{r|Sudden cardiac death}} | {{r|Sudden cardiac death}} | ||
{{Bot-created_related_article_subpage}} | |||
<!-- Remove the section above after copying links to the other sections. --> | <!-- Remove the section above after copying links to the other sections. --> |
Revision as of 14:53, 11 January 2010
- See also changes related to Defibrillator, or pages that link to Defibrillator or to this page or whose text contains "Defibrillator".
Parent topics
Subtopics
Bot-suggested topics
Auto-populated based on Special:WhatLinksHere/Defibrillator. Needs checking by a human.
- Advanced cardiac life support [r]: The use of methods and equipment, beyond the level of cardiopulmonary resuscitation but less than surgical or interventional cardiology, to treat cardiopulmonary arrest. [e]
- Artificial pacemaker [r]: A device that temporarily or indefinitely substitutes for the heart's electrical triggering system [e]
- Atrial fibrillation [r]: Condition where there is disorganised electrical conduction in the atria, resulting in ineffective pumping of blood into the ventricle. [e]
- Cardio Pulmonary Resuscitation [r]: An emergency medical procedure for a victim of cardiac arrest. [e]
- Homeopathy [r]: System of alternative medicine involving administration of highly diluted substances with the intention to stimulate the body's natural healing processes, not considered proven by mainstream science. [e]
- Life extension [r]: Medical and non-medical attempts to slow down or reverse the processes of aging, to extend both the maximum and average lifespan. [e]
- New drug application [r]: The U.S. regulatory process under which the Food and Drug Administration authorizes the marketing of new drugs, for which it has verified safety and efficacy for specific disease indication; the prescribing information must warn of potential adverse effects [e]
- Sudden cardiac death [r]: The cessation of effective heart pumping within one hour of the onset of symptoms [e]